← back to search

Jinglin Li

Xi'an Jiaotong University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, Cholangiocarcinoma and Gallbladder Cancer Studies, MicroRNA in disease regulation, and RNA modifications and cancer.
h-index
19
citations
1,279
works
47
NIH funding
primary concept
Medicine
email

Recent publications

Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
Frontiers in Medicine 2023cited by 29position: middledoi
Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review
Journal of Clinical and Translational Hepatology 2023cited by 19position: middledoi
YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2
International Journal of Biological Sciences 2022cited by 26position: firstdoi
A Circular RNA, Cholangiocarcinoma‐Associated Circular RNA 1, Contributes to Cholangiocarcinoma Progression, Induces Angiogenesis, and Disrupts Vascular Endothelial Barriers
Hepatology 2020cited by 233position: middledoi
SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN
Aging 2020cited by 46position: firstdoi
Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p
Human Cell 2020cited by 30position: firstdoi
AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8
Aging 2020cited by 25position: middledoi
Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation
Cancer Cell International 2020cited by 12position: middledoi
Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation
Research Square 2020cited by 1position: middledoi
Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway
Cell Death and Disease 2019cited by 49position: middledoi
LncRNA‐MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma
Journal of Cellular Physiology 2019cited by 40position: firstdoi
Functions and roles of long noncoding RNA in cholangiocarcinoma
Journal of Cellular Physiology 2019cited by 29position: firstdoi
Up‐regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR‐296‐5p
Journal of Cellular and Molecular Medicine 2019cited by 27position: middledoi
The role of long non-coding RNA AFAP1-AS1 in human malignant tumors
Pathology - Research and Practice 2018cited by 57position: middledoi
Long noncoding RNA GHET1 in human cancer
Clinica Chimica Acta 2018cited by 17position: firstdoi
Current insight into a cancer-implicated long noncoding RNA ZFAS1 and correlative functional mechanisms involved
Pathology - Research and Practice 2018cited by 12position: middledoi
Lnc<scp>RNA</scp>‐<scp>ATB</scp>: An indispensable cancer‐related long noncoding <scp>RNA</scp>
Cell Proliferation 2017cited by 172position: firstdoi
<scp>ZEB</scp>1‐<scp>AS</scp>1: A crucial cancer‐related long non‐coding <scp>RNA</scp>
Cell Proliferation 2017cited by 78position: firstdoi
PANDAR: a pivotal cancer-related long non-coding RNA in human cancers
Molecular BioSystems 2017cited by 32position: firstdoi
Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion
Gene 2017cited by 29position: middledoi
Progress of long non-coding RNA LINC00152 in gastrointestinal cancer
Zhongliu yanjiu yu linchuang 2017cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xingming Jiang · Harbin Medical University18 papers (2017–2022)Yunfu Cui · Harbin Medical University17 papers (2017–2023)Zhenglong Li · Harbin Medical University15 papers (2017–2020)Yi Xu · Central South University9 papers (2017–2023)Lining Huang · Harbin Medical University9 papers (2018–2020)Xiangyu Zhong · Tohoku University7 papers (2018–2023)Daolin Ji · Harbin Engineering University7 papers (2017–2020)Pengcheng Kang · Harbin Medical University7 papers (2018–2023)Kaiming Leng · Qingdao University6 papers (2017–2020)Wangyang Zheng · Third Affiliated Hospital of Harbin Medical University5 papers (2017–2022)Zhidong Wang · Harbin Medical University4 papers (2017–2022)Zengtao Hu · Harbin Medical University4 papers (2020–2020)Chunlong Li · Huazhong Agricultural University3 papers (2018–2020)Canghai Guan · Harbin Medical University3 papers (2020–2023)Zhilei Su · Central South University3 papers (2018–2020)Xinheng Li · Harbin Medical University3 papers (2017–2017)Yongxu Zhou · Kookmin University2 papers (2020–2020)Sheng Tai · Harbin Medical University2 papers (2019–2020)Yunfu Cui · Harbin Medical University2 papers (2019–2020)Lining Huang · Hebei Medical University2 papers (2017–2017)